Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Buy the Recovery or Sell into Strength as AI Hopes Rise?

Published

on

Google's New 'Daily Listen' Turns Your Discover Feed Into Podcast

NEW YORK — Investors debating whether to buy or sell SolarEdge Technologies (SEDG) stock in 2026 face a classic turnaround story: a solar inverter leader battered by high interest rates and European market slowdowns but showing early signs of recovery fueled by U.S. policy support, improving margins and potential new growth from AI data center power solutions.

As of mid-May 2026, SolarEdge shares trade around $50-62 after a sharp rebound from earlier 2026 lows near $32. The stock has gained more than 90 percent year-to-date, reflecting renewed optimism, yet most Wall Street analysts maintain a Hold rating with an average price target near $35-38, suggesting limited near-term upside or even downside risk from current levels.

The company’s first-quarter 2026 results, released in early May, showed revenue of $310.5 million — up 46 percent year-over-year — and non-GAAP gross margins of 23.5 percent. Management guided for Q2 revenue between $325 million and $355 million and expressed confidence in approaching break-even operating profitability soon. CEO Shuki Nir highlighted “the most optimism in a long time,” citing the Nexis platform rollout and AI-related opportunities.

Reasons to Buy SolarEdge in 2026

Several factors support a bullish case. U.S. policy tailwinds, including extended manufacturing and storage tax credits, are expected to drive residential and commercial solar demand. SolarEdge’s focus on optimizers and smart energy management gives it a technological edge over basic inverter competitors. The company is also positioning itself in the growing AI data center power market, where reliable, efficient energy solutions are in high demand.

Advertisement

Analysts at firms like TD Cowen and Susquehanna have raised price targets recently, citing improving execution and margin expansion. Long-term growth projections show revenue compounding at 14-15 percent annually through 2028, driven by product innovation and geographic diversification. At current valuations, the stock offers a compelling risk-reward for investors with a 12-24 month horizon who believe the solar recovery is sustainable.

Dividend potential and a strengthening balance sheet add further appeal. SolarEdge has been generating positive free cash flow in recent quarters, providing flexibility for share repurchases or strategic investments.

Reasons to Sell or Stay Cautious

However, risks remain significant. Consensus analyst targets imply downside from current levels, with several firms citing concerns over U.S. residential demand softening if certain tax credits are reduced. Competition from lower-cost Chinese manufacturers continues to pressure pricing, and any resurgence of high interest rates could slow project financing again.

Valuation remains stretched on some metrics despite the recent recovery. The stock trades at a premium to historical averages on a price-to-sales basis, and profitability has yet to fully recover. Geopolitical risks, supply chain issues and execution challenges in new product lines could derail the turnaround narrative.

Advertisement

Short interest remains elevated, reflecting skepticism among some investors. Recent price action shows volatility, with sharp moves on earnings and news flow typical for a high-beta recovery story.

Balanced Investment Thesis for 2026

For growth-oriented investors, SolarEdge represents a high-conviction play on the global energy transition and AI infrastructure buildout. The company’s technology leadership in module-level power electronics and energy optimization positions it well for market share gains as solar adoption accelerates. A successful Nexis platform launch and AI data center expansion could act as powerful catalysts later in the year.

Conservative investors or those seeking income may prefer to wait for clearer signs of sustained profitability and lower valuations. Dollar-cost averaging on dips or using options strategies could help manage risk in this volatile name.

Diversification is key. Pairing SolarEdge with more stable renewable plays or broader market exposure can balance the portfolio. Long-term holders who bought during the 2025 lows have already seen strong returns, but new entrants should size positions carefully given the stock’s history of sharp swings.

Advertisement

Broader Solar Sector Outlook

The solar industry faces a mixed but improving backdrop in 2026. Policy support in the U.S. and Europe, combined with falling panel prices and technological advancements, supports long-term growth. However, near-term challenges including interest rates, permitting delays and grid constraints remain. Companies like SolarEdge that offer differentiated, high-value solutions are better positioned than pure commodity players.

SolarEdge’s pivot toward storage integration and smart energy management aligns with industry trends toward holistic energy systems. Success here could expand total addressable market significantly beyond traditional inverters.

Final Recommendation

SolarEdge is a speculative buy for investors comfortable with volatility and bullish on the energy transition and AI power demand. The stock offers asymmetric upside if execution continues improving and new growth drivers materialize. However, near-term risks from policy changes, competition and profitability timelines suggest caution for conservative portfolios.

A blended strategy — initiating a core position with plans to add on weakness while maintaining strict risk management — may suit most investors. As always, conduct thorough due diligence and consider consulting a financial advisor. SolarEdge’s story in 2026 is one of cautious optimism: a beaten-down leader showing signs of a sustainable recovery in a sector with strong structural tailwinds.

Advertisement

The coming quarters will be critical as management delivers on guidance and new initiatives. For those willing to weather volatility, SolarEdge could reward patience with significant upside as the solar and AI stories converge. For others, waiting for more consistent profitability and lower valuations may prove prudent. The solar recovery trade is alive in 2026 — the question is whether SolarEdge can lead it.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

FDA drug center head fired after commissioner’s exit

Published

on

FDA drug center head fired after commissioner’s exit


FDA drug center head fired after commissioner’s exit

Continue Reading

Business

Amazon: Sell Before The Cash Flow Gets Worse

Published

on

Amazon: Sell Before The Cash Flow Gets Worse

Amazon: Sell Before The Cash Flow Gets Worse

Continue Reading

Business

Kyivstar Group Ltd. (KYIV) Q1 2026 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Operator

Hello, and welcome to Kyivstar’s 1Q ’26 Results Presentation. [Operator Instructions] As a reminder, this conference is being recorded today. [Operator Instructions]

Cole Akeson, you may begin.

Advertisement

Cole Akeson
Group Director of Investor Relations

Thank you. Good afternoon, and good morning. Thank you all for joining us to discuss Kyivstar Group’s or Kyivstar’s first quarter results. I am Cole Akeson, Group Director for Kyivstar Investor Relations. Joining me today are Kaan Terzioglu, Chairman of the Board; Oleksandr Komarov, the CEO; Boris Dolgushin, our CFO; and Anand Ramachandran, Chief Corporate Development Officer for VEON. Oleksandr will begin with strategic and operational highlights, followed by Boris with a review of our financial performance. We will then open the line for questions.

Before we begin, please note that today’s presentation contains forward-looking statements, which involve risks and uncertainties. Further details are available in our SEC filings, including our Form 20-F filed March 16, 2026. Our earnings release and presentation are available on our Investor Relations website.

With that, I’ll hand over to Oleksandr.

Advertisement

Oleksandr Komarov
President

Thank you, Cole. Hello, everyone. We started 2026 with strong execution. Our telecom core is resilient. Our digital ecosystem is scaling. The 2 businesses fit each other.

Let

Advertisement
Continue Reading

Business

Avax One Technology Ltd. (AVX) Q1 2026 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Operator

Good afternoon, everyone and thank you for participating in today’s conference call to discuss Avax One’s financial and operating results for the first quarter ended March 31, 2026. Joining us today are the company’s Chief Executive Officer, Jolie Kahn; and Chief Financial Officer, Chris Polimeni.

By now, everyone should have access to Avax’s First Quarter 2026 earnings press release, which was issued earlier this afternoon at approximately 4:05 p.m. Eastern Time. The release is available in the Investor Relations section of the company’s website at www.avax-one.com. This call will also be available for webcast replay on the company’s website.

Following management’s remarks, we’ll open up the call for your questions. Please be advised this conference call will contain statements that are considered forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain known and unknown risks and uncertainties as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These forward-looking statements are also subject to other risks and uncertainties that are described from time to time in the company’s filings with the SEC. Do not place undue reliance on any forward-looking statements, which are being made only as of the date of this call, except as required by law, the company undertakes no obligation to publicly update or revise any forward-looking statements.

Advertisement

For important risks and assumptions associated with such forward-looking statements, please refer to the company’s SEC filings. Now over to you, Jolie.

Continue Reading

Business

EUFN: European Financials Remain Attractively Valued Ahead Of Potential Rate Hikes (EUFN)

Published

on

EUFN: European Financials Remain Attractively Valued Ahead Of Potential Rate Hikes (EUFN)

This article was written by

I ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets and the economy that has not faded despite the years. More recently I have been combining long stock positions with covered calls and cash secured puts. I approach investing purely from a fundamental long-term point of view. On Seeking Alpha I mostly cover REITs and financials, with occasional articles on ETFs and other stocks driven by a macro trade idea.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Ironwood Pharmaceuticals, Inc: Still A Profitable Opportunity

Published

on

Incyte: An Undervalued Healthcare Gem

Ironwood Pharmaceuticals, Inc: Still A Profitable Opportunity

Continue Reading

Business

BlackRock weighs multibillion-dollar investment in SpaceX IPO, the Information reports

Published

on

BlackRock weighs multibillion-dollar investment in SpaceX IPO, the Information reports


BlackRock weighs multibillion-dollar investment in SpaceX IPO, the Information reports

Continue Reading

Business

China says Trump visit deals are ’preliminary’

Published

on

China says Trump visit deals are ’preliminary’


China says Trump visit deals are ’preliminary’

Continue Reading

Business

Earnings call transcript: Innate Pharma Q1 2026 beats earnings expectations

Published

on


Earnings call transcript: Innate Pharma Q1 2026 beats earnings expectations

Continue Reading

Business

China signals tariff cuts, advances in farm market access after Trump-Xi summit

Published

on

China signals tariff cuts, advances in farm market access after Trump-Xi summit


China signals tariff cuts, advances in farm market access after Trump-Xi summit

Continue Reading

Trending

Copyright © 2025